"Contrary to what a few here claim, the sp didn't fall to the 5c...

First 269 Last

Share
Profile

Follow
riverflows

503 Posts.

158

01/06/24

11:31

Post #: 74116406
Share

Originally posted by chuk: ↑

If I was you and I thought that, I wouldn't be holding. I have seen this stock climb in anticipation of news a number of times, including ahead of the IDC decision. Most stocks do the same.
Contrary to what a few here claim, the sp didn't fall to the 5c range because of a claimed increased funding risk. It's much more likely the sp fell because of the further delay to production to April next year and due to the cr. The funding risk actually decreased significantly with the IDC approval.

The sp was averaging 9c in the several months prior to the IDC completing it due diligence and its credit committee approving the loan. You can also see the sp climbed from 7c to 10c, a near 50% gain, ahead of that decision and that was despite a lot of concerns here that the decision was taking longer than expected and that could have been seen as a higher risk that the loan would not be approved. If the sp climbed strongly ahead of that decision, which was seen as late, why would it fall ahead of the remaining funding news when that remaining funding risk has dropped sharply following the IDC loan approval?

Expand

"Contrary to what a few here claim, the sp didn't fall to the 5c range because of a claimed increased funding risk. It's much more likely the sp fell because of the further delay to production to April next year and due to the cr."

Based on what you said above, what stops the sp from crashing further even from here if there's another delay until 2026, so MNB has to pay for 1 extra year of directors' increased remuneration, and having to raise a few extra CRs along the way until production?

Last edited by riverflows: 01/06/24

MNB Price at posting: 5.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

ASX Market Open: ASX200 to rise for Friday session | July 26

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement